RxDoctor Payments Data

Oscar Lu, DO

Family Medicine · Olathe, KSNPI 1649775735

Payments from drug & device makers

$847in general payments, 2019–2025

Across 71 payments — averaging $11.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$403
  • Kowa Pharmaceuticals America, Inc.$96
  • Idorsia Pharmaceuticals US Inc$87
  • Novo Nordisk$54
  • Merck$49
  • Lilly USA, LLC$37
  • plus $122 from 7 others

What the payments were for

  • Food & beverage$847100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$847 in reported general payments places this provider in the 60th percentile of 1,469 family medicine providers in Kansas.

See all family medicine providers in Kansas

Medicare billing

Part B allowed, 2024
$42,646
Medicare patients
128
Services billed
918

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide23$30,419
MounjaroTirzepatide19$22,838
EliquisApixaban22$18,924
FarxigaDapagliflozin Propanediol14$17,371
JardianceEmpagliflozin22$12,928
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$11,267
MyrbetriqMirabegron18$11,101
SeroquelQuetiapine Fumarate13$4,825
Lantus SolostarInsulin Glargine,hum.Rec.Anlog34$4,164
Novolog FlexpenInsulin Aspart17$3,864
Arnuity ElliptaFluticasone Furoate13$2,858
Rosuvastatin Calcium165$2,541
Divalproex Sodium ErDivalproex Sodium18$2,424
Methylphenidate ErMethylphenidate Hcl12$2,341
Fluticasone-SalmeterolFluticasone Propion/Salmeterol26$2,196

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$54$30,41923 claims
Lilly USA, LLCMounjaro$37$22,83819 claims
AstraZenecaFarxiga, Seroquel$13$22,19527 claims
GSKTrelegy Ellipta, Arnuity Ellipta$14$14,12525 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 1,469 family medicine providers in Kansas.

Other family medicine in Olathe

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →